Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04410978
Brief Title: Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

First Submitted : May 28, 2020
First Submitted that Met QC Criteria : May 28, 2020
First Posted : June 1, 2020

Last Update Submitted that Met QC Criteria : July 12, 2021
Last Update Posted : July 13, 2021